Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MycoMed Technologies
AddedFeb 18, 2024
UpdatedJun 18, 2026
MycoMed Technologies

MycoMed Technologies

Angel

MycoMed Technologies: Innovating early detection and prevention of fungal infections in vulnerable patients.

HQ
Baltimore, MD, US
Founded
2014
Overview
Compare
Fundraising
Employees

MycoMed Technologies is dedicated to developing and commercializing products for the early detection and prevention of fungal infections in patients undergoing organ transplants, cancer therapy, or immunosuppressant treatments. The company aims to improve patient outcomes by providing timely and accurate diagnostic solutions.

MycoMed Technologies has made significant strides in the healthcare sector, particularly in enhancing the safety and well-being of immunocompromised patients. Their innovative approach has garnered attention and support, contributing to advancements in medical diagnostics and patient care.

MycoMed Technologies - Similar Companies

MycoMedica Life Sciences logo

MycoMedica Life Sciences

mycomedica.bio

Mycologics logo

Mycologics

mycologics.net

MiniVax logo

MiniVax

Zymeron logo

Zymeron

zymeron.com

BiomedInnovations logo

BiomedInnovations

Intellimedix logo

Intellimedix

Micronoma logo

Micronoma

micronoma.com

PathogenDx logo

PathogenDx

pathogendx.com

MeCo Diagnostics logo

MeCo Diagnostics

Amplified Sciences logo

Amplified Sciences

MYi logo

MYi

Kathera Bioscience logo

Kathera Bioscience

katherabio.com

Prevacept Infection Control logo

Prevacept Infection Control

Mycoinnovation logo

Mycoinnovation

Mycelial logo

Mycelial

mycelial.co

MycoMed Technologies - Quick Facts

Who are MycoMed Technologies' competitors?

Companies similar to MycoMed Technologies include MycoMedica Life Sciences, Mycologics, MiniVax and Zymeron.

When was MycoMed Technologies founded?

MycoMed Technologies was founded in 2014.

Where is MycoMed Technologies' headquarters located?

MycoMed Technologies' headquarters is located in Baltimore, MD, US.

When was MycoMed Technologies' last funding round?

MycoMed Technologies' most recent funding round was for $175k (USD) in June 2015.

How much has MycoMed Technologies raised to-date?

As of Jun 26, 2015, MycoMed Technologies has raised a total of $175k (USD).

How many employees does MycoMed Technologies have?

MycoMed Technologies has 30 employees as of Feb 4, 2024.

MycoMed Technologies - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Medical Devices
Tags
  • Healthtech